US2024009357A1PendingUtilityA1
3d printing of biomedical implants
Est. expiryApr 29, 2035(~8.8 yrs left)· nominal 20-yr term from priority
A61L 31/06C08J 3/24B33Y 80/00B29C 64/135B29C 41/22B29C 41/00B33Y 30/00B33Y 70/00B29C 64/20A61L 31/16A61L 31/18C09D 167/06C08J 2367/06B29K 2995/0056B29L 2031/7534B33Y 10/00A61F 2/82A61F 2240/001B29K 2033/00B29K 2105/0005B29K 2995/006
76
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Provided herein are methods, compositions, devices, and systems for the 3D printing of biomedical implants. In particular, methods and systems are provided for 3D printing of biomedical devices (e.g., endovascular stents) using photo-curable biomaterial inks (e.g., or methacrylated poly(diol citrate)).
Claims
exact text as granted — not AI-modified1 . A system comprising:
(a) a photo-curable biomaterial ink; and (b) a 3D printing device for:
(i) dispensing a layer of the photo-curable biomaterial ink in a pattern according to encoded instructions,
(ii) exposing the layer of the photo-curable biomaterial ink to light to cure the biomaterial ink and produce a solidified biomaterial layer, and
(iii) repeating steps (i) and (ii), with each successive layer built upon the previous layer to produce a 3D structure of the solidified biomaterial.
2 . The system of claim 1 , wherein the photo-curable biomaterial ink comprises methacrylated poly(diol citrate).
3 . The system of claim 1 , wherein the poly(diol citrate) comprises a polymer of citric acid and HO—(CH 2 ) n —OH, wherein n is 2-20.
4 . The system of claim 1 , wherein the photo-curable biomaterial ink further comprises one or more of: a solvent, a photoinitiator, a co-initiator, a free-radical quencher, and a UV-absorber.
5 . The system of claim 1 , wherein the 3d printing device is configured for laser scanning stereolithography, projection stereolithography, ink-jet printing, continuous liquid interface production, or combinations thereof.
6 - 17 . (canceled)Join the waitlist — get patent alerts
Track US2024009357A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.